Miri Ziv, ICA's Vice Chairman (and Former Director General), is a Medical Sociologist and serves as a consultant for the Israeli medical authorities, providing guidance on issues relating to cancer control. One of her main areas of expertise and interest lies in the area of breast cancer advocacy.
Miri is active both locally and abroad. She works towards initiating and implementing national projects, especially in the area of cancer control, for example, she initiated steps that led to the implementation of the National Mammography Screening Program in Israel, Skin Cancer Awareness Month, as well as countless other programs to raise awareness and promote early detection, methods of prevention and new means of rehabilitation for patients and survivors.
Miri earned an M.A. degree in Medical Sociology, with distinction, at the Tel-Aviv University, and completed the study requirements for the PhD. program. Additionally, she taught Medical Sociology at Tel Aviv University for about a decade.
She is a graduate of the NBCC American Breast Cancer Coalition Project Lead® and of the 92nd St. Y. Ford Fellowship Program in New York - Developing Community Leaders - in collaboration with Columbia University.
Has served for 20 years as a Member of The Israel National Health Committee (appointed by the Minister of Health).
Is currently Coordinator of The Israel National Council of Oncology.
Is a Member of The National Council for Women's Health, the National Council of Health Promotion (all appointed by the Director General of the Ministry of Health).
Is an Executive Board Member of The Israel Health Consumers Coalition.
In honor of International women's day 2018, "Haaretz" newspaper published an article on "Groundbreaking Women". Miri Ziv, Director General of the Israel Cancer Association, participated in the interview, published on the 8th of March, 2018
Has been serving since 1995 as a National Representative of the European Breast Cancer Coalition - Europa Donna (E.D.) (served as a Member of the Executive Board from 1995 to 2000).
Served from 1992-2002 on the Executive Board of the European Cancer Leagues (ECL).
Was selected in 2006 to serve on the Executive Board of the Union for International Cancer Control (UICC), serving therein for 2 maximum terms.
Serves as a Member of the Executive Board of S.I.S. (Senologic International Society, the World Society of Breast Diseases) and recently in October 2014, was appointed as a Member of the S.I.S. Presidential Ad Hoc Committee for 2015-2016.
Has been appointed by Prof. Peter Boyle as a Senior Research Fellow of the International Prevention Research Institute (IPRI).
Has been appointed ESMO Faculty Member for Cancer Prevention.
In 2005, Miri received the "Best CEO in Israel" Award, presented by the Israel Association of Public Relations, for her innovative and creative activities alongside her profound management skills.
A gold medal of appreciation was awarded to Mrs. Miri Ziv by the Israeli Society of Clinical Oncology & Radiation Therapy (ISCORT) for "her outstanding contribution to the Society's activities". The medal of appreciation was awarded at the annual conference of the Society held in January 2011, marking a decade of ISCORT annual conferences.
Miri was also elected as Global Cancer Ambassador by the American Cancer Society to participate in activity at the UN Headquarters in New York, and was invited to participate in the Israeli delegation to the historic UN General Assembly High-Level meeting on NCDs in September 2011.
The American Association for Cancer Research (AACR) presented the 2015 AACR Award for Distinguished Public Service and Global Impact in Cancer Advocacy to Miri at the AACR Annual Meeting held in April, in Philadelphia, U.S. The award was presented to Miri for her lifelong contribution to the public's health and wellbeing, as well as her global achievements in furthering the fight against cancer.
Long before her experience of personal tragedy some 22 years ago, when she lost her son to cancer, as well as her brother 13 years ago, Miri acted with resolve and passion to initiate and implement plans for the prevention and early detection of cancer on a national level. Needless to say, her determination grew even stronger.